World & BusinessInnoCare and Eli Lilly sign collaboration deal worth up to about $3.35 billion
Reuters reports that Chinese drugmaker InnoCare Pharma announced a research collaboration and licensing agreement with Eli Lilly.
TLDR
InnoCare Pharma said on September 24, 2026, that it had entered a research collaboration and licensing agreement with Eli Lilly worth up to about $3.35 billion, Reuters reports.
InnoCare and Eli Lilly sign collaboration deal worth up to about $3.35 billion
Reuters reports that Chinese drugmaker InnoCare Pharma announced a research collaboration and licensing agreement with Eli Lilly.
TLDR
InnoCare Pharma said on September 24, 2026, that it had entered a research collaboration and licensing agreement with Eli Lilly worth up to about $3.35 billion, Reuters reports.